Project Grant R01AI185041
- This federal Project Grant award, totaling $184,680, was provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to investigate the role of itch-sensing neurons in skin immunity against helminth infections. The research aims to determine how the parasitic helminth Schistosoma mansoni inhibits certain itch-inducing neurons (MRGPRA3) that promote skin inflammation and anti-parasitic immunity, while preferentially stimulating...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $769,366 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective from February 1, 2025 to January 31, 2030, aims to decipher the ontogeny of CD4+ resident memory T cells that globally seed the skin and protect against cutaneous leishmaniasis. The...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports scientific research focused on understanding the immune response to peripheral nerve injury in mice. The $531,478 award to the Regents of the University of Michigan will fund a longitudinal analysis combining flow cytometry and single-cell RNA sequencing to explore the distinct and...
- This Project Grant award of $409,887.00 from the National Institute of Neurological Disorders and Stroke (NINDS) Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to investigate the mechanisms leading to small fiber neuropathy and loss of epidermal nerve fibers. The research aims to explore whether epidermal axons comprise a surveillance network that responds to threats on body surfaces, leading to nerve fiber density loss. Key areas...
- This federal Project Grant award, valued at $1,826,181.00 and effective from September 1, 2025 to August 31, 2028, was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research grant program (CFDA 93.846). The grant aims to comprehensively understand the contribution of Langerhans cells, resident cells in the epidermis, to chronic itch associated with various skin and systemic diseases. The research...
- This $169,560.00 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research focused on understanding the role of the endogenous opioid system in regulating inflammation, itch, and pain associated with inflammatory skin diseases. The primary recipient, The Regents of the University of California, San Francisco (UCSF), will conduct this research...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $417,845 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC) to adapt an in vitro human skin model for studying Borrelia burgdorferi transmission and colonization by the blacklegged deer tick (Ixodes scpaularis). The project aims to modify the skin model to increase tick feeding efficiency, demonstrate B. burgdorferi transmission and...
- This $429,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of Schwann cell PIEZO1 in pain sensation. The key objectives are to: 1) develop and validate adeno-associated virus (AAV) vectors for selective inhibition of Schwann cell PIEZO1, and 2) determine the sensory effects of Schwann cell...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $847,000 Project Grant through the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Kentucky Research Foundation. The purpose of this 2.5-year award, beginning July 2025, is to investigate the protective roles of the CD180 and NOD1 molecules in the immune response against cerebral Toxoplasma gondii infection. The research aims to better understand how these pathogen-associated molecular...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $228,000 to Kansas State University to study the role of nociceptor sensory neurons and neuropeptide signaling in modulating host immune responses to pneumonic sepsis caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. The research aims to elucidate how nociceptor neurons and their neuropeptide...
NEURO-IMMUNE MECHANISMS AGAINST SKIN-PENETRATING HELMINTHS - NEURO-IMMUNE MECHANISMS AGAINST SKIN-PENETRATING HELMINTHS SUMMARY DIVERSE HELMINTH SPECIES ESTABLISH HOST INFECTION THROUGH DIRECT SKIN PENETRATION, BUT THE MECHANISMS OF CUTANEOUS IMMUNITY ARE POORLY UNDERSTOOD. CURIOUSLY, PERCUTANEOUS INFECTION OF OVER 250 MILLION PEOPLE WITH THE WATER-BORNE BLOOD FLUKE SCHISTOSOMA MANSONI OFTEN GOES UNNOTICED AND MOST OF THESE INDIVIDUALS EXPERIENCE FREQUENT RE-INFECTION DUE TO POOR IMMUNE RESPONSES TO SKIN-PENETRATING LARVAE. WHETHER A MECHANISTIC LINK EXISTS BETWEEN IMPAIRED PROTECTIVE IMMUNITY AND FAILURE OF SKIN AFFERENT NEURONS TO RELEASE IMMUNOSTIMULATORY FACTORS IS A MAJOR GAP IN OUR CURRENT UNDERSTANDING OF HOST IMMUNITY. MOREOVER, THE ROLE OF THE ALARMIN CYTOKINE INTERLEUKIN 33 (IL-33) IN DRIVING HOST RESISTANCE OR SUSCEPTIBILITY TO SKIN PENETRATION BY HELMINTH LARVAE HAS NOT BEEN TESTED. OUR DATA REVEAL THAT PRE-EMPTIVE ACTIVATION OF MOUSE SKIN-AFFERENTS DRIVES INNATE RESISTANCE TO PARASITE INVASION ACCOMPANIED BY THE RECRUITMENT OF INTERLEUKIN (IL)-17-PRODUCING CD4 AND GD T CELL SUBSETS, AND INFLAMMATORY MONOCYTES. SURPRISINGLY, SKIN NEURON ACTIVATION ALSO RAPIDLY DEPLETES IL-33 IN TISSUE MACROPHAGES AND TYPE 2 CONVENTIONAL DENDRITIC CELLS (CDC2), BUT NOT SKIN FIBROBLASTS. INDEED, MICE WITH A GENETIC DELETION OF IL-33 ONLY IN CD11C+ MYELOID ANTIGEN PRESENTING CELLS (APC) PHENOCOPY HOST IMMUNE RESPONSES IN WILD-TYPE MICE WITH ACTIVATED SKIN-SENSORY NEURONS. THIS PROJECT SEEKS TO IDENTIFY THE SPECIFIC NEURON SUBSETS AND THE SOLUBLE MEDIATORS THEY RELEASE THAT DRIVE HOST RESISTANCE AND DISCERN WHETHER SUCH PROTECTION REQUIRES LOSS OF MYELOID-SPECIFIC IL-33. ONE OF THE KEY IMMUNOREGULATORY NEUROPEPTIDES RELEASED BY SKIN AFFERENTS IS CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND OUR DATA SHOW THAT CGRP ADMINISTRATION RESULTS IN MYELOID APC- INTRINSIC LOSS OF IL-33 THROUGH UNKNOWN MECHANISM(S). THEREFORE, OUR CENTRAL HYPOTHESIS THAT ITCH-RESPONSIVE SKIN NEURONS INITIATE HOST RESISTANCE TO SKIN PENETRATING HELMINTHS VIA CGRP-MEDIATED REDUCTION OF MYELOID-SPECIFIC IL-33, WHICH INITIATES PRODUCTION OF IL-17-PROMOTING CYTOKINES FROM SKIN MACROPHAGE AND CDC SUBSETS. THE TWO SPECIFIC AIMS OF THIS PROPOSAL ARE TO: (1) IDENTIFY THE NEURON SUBSETS NECESSARY AND SUFFICIENT FOR SKIN RESISTANCE TO HELMINTH INFECTION AND (2) DETERMINE HOW CGRP CAUSES DECREASE IN MYELOID- SPECIFIC IL-33 AND HOST RESISTANCE TO PARASITE INVASION. SUCCESSFUL COMPLETION OF THIS PROJECT DESIGNED TO UNDERSTAND HOW SENSORY NEURON-APC INTERACTIONS CONTROL HOST PROTECTION AND IL-33 EXPRESSION STANDS TO PROVIDE KEY INSIGHT(S) FOR DEVELOPING PREVENTATIVE MEASURES AGAINST HELMINTH SKIN PENETRATION IN HUMANS, WHICH DO NOT CURRENTLY EXIST.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $678.7k | 5/14/25 | ||
| Not listed | ($22k) | 5/6/25 | ||
| Not listed | ($22k) | 5/6/25 | ||
| Not listed | $22.3k | 5/6/25 | ||
| Not listed | $22.3k | 5/6/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
501136S | Monell Chemical Senses Center | Project Grant R01AI185041 | $91.1k | 9/18/24 |